C17H16N6O
Neat
320.36
Ruxolitinib metabolite M9; INCB-25255; UNII-38H7H33E44; 38H7H33E44; (3R)-3-(3-Oxocyclopentyl)-3-(4-(7H-pyrrolo(2, 3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile; 1092973-96-0; 1H-Pyrazole-1-propanenitrile, beta-(3-oxocyclopentyl)-4-(7H-pyrrolo(2, 3-d)pyrimidin-4-yl)-; Ruxolitinib Impurity 207; Q27256787; 1809535-64-5; 1H-PYRAZOLE-1-PROPANENITRILE, .BETA.-(3-OXOCYCLOPENTYL)-4-(7H-PYRROLO(2 and 3-D)PYRIMIDIN-4-YL)-
(3R)-3-(3-oxocyclopentyl)-3-[4-(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile
InChI=1S/C17H16N6O/c18-5-3-15(11-1-2-13(24)7-11)23-9-12(8-22-23)16-14-4-6-19-17(14)21-10-20-16/h4,6,8-11,15H,1-3,7H2,(H,19,20,21)/t11?,15-/m1/s1